Prescription Required
Esnotone Plus Tablet may cause excessive drowsiness with alcohol.
Esnotone Plus Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Esnotone Plus Tablet during breastfeeding is not available. Please consult your doctor.
Esnotone Plus Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Esnotone Plus Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Esnotone Plus Tablet may not be needed in these patients. Please consult your doctor.<BR>Use of Esnotone Plus Tablet may cause excessive sleepiness in patients with end stage kidney disease.
Esnotone Plus Tablet should be used with caution in patients with liver disease. Dose adjustment of Esnotone Plus Tablet may be needed. Please consult your doctor.<BR>Limited information is available on the use of Esnotone Plus Tablet in these patients.
Esnotone Plus Tablet is a combination of three medicines: Guaifenesin, Diethylcarbamazine and Chlorpheniramine Maleate which treat parasitic infections. Guaifenesin is an expectorant which decreases the stickiness of mucus (phlegm), helping in its removal from the airways. Diethylcarbamazine is an antiparasitic medicine which works by decreasing the muscular activity and causing paralysis of the worms. Chlorpheniramine Maleate is an antiallergic which decreases the raised eosinophil count (white blood cells) and controls allergic symptoms like cough and breathlessness.
Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA